← back to search

David Gurwitz

Tel Aviv University · IL
Area of research
Pharmacology · Molecular Biology
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, and Alzheimer's disease research and treatments.
h-index
49
citations
9,871
works
312
NIH funding
primary concept
email

Recent publications

Biallelic null variants in C19orf44 cause a unique late-onset retinal dystrophy phenotype characterized by patchy perifoveal chorioretinal atrophy
Genetics in Medicine 2025cited by 3position: middledoi
Machine Learning-Based Blood RNA Signature for Diagnosis of Autism Spectrum Disorder
International Journal of Molecular Sciences 2023cited by 29position: lastdoi
Immunoglobulin genes expressed in lymphoblastoid cell lines discern and predict lithium response in bipolar disorder patients
Molecular Psychiatry 2023cited by 18position: middledoi
Blood RNA Sequencing Indicates Upregulated BATF2 and LY6E and Downregulated ISG15 and MT2A Expression in Children with Autism Spectrum Disorder
International Journal of Molecular Sciences 2022cited by 5position: lastdoi
Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics
Drug Development Research 2020cited by 835position: firstdoi
Pharmacogenomics Education in Medical and Pharmacy Schools: Conclusions of a Global Survey
Pharmacogenomics 2019cited by 88position: middledoi
Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action
Proceedings of the National Academy of Sciences 2018cited by 62position: middledoi
Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies
The Pharmacogenomics Journal 2016cited by 57position: middledoi
The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases
European Journal of Human Genetics 2014cited by 82position: middledoi
The EU-ADR corpus: Annotated drugs, diseases, targets, and their relationships
Journal of Biomedical Informatics 2012cited by 150position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Adi Aran · Palo Alto University2 papers (2022–2023)Richard E. Frye · University of Arizona2 papers (2022–2023) · 2 papers (2022–2023) · 1 papers (2025–2025)Ifat Sher · Monash Health1 papers (2025–2025)Andrew R. Webster · The London College1 papers (2025–2025) · 1 papers (2018–2018) · 1 papers (2019–2019)Mariam Molokhia · King's College London1 papers (2012–2012) · 1 papers (2019–2019) · 1 papers (2025–2025)Sandeep Sarma Asodu · Hebrew University of Jerusalem1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2018–2018) · 1 papers (2025–2025) · 1 papers (2025–2025)Jeantine E. Lunshof · Harvard University1 papers (2019–2019)Carlo Rivolta · University of Lausanne1 papers (2025–2025) · 1 papers (2018–2018)Jan A. Kors · Nederlands Olympisch Comité Nederlandse Sport Federatie1 papers (2012–2012)